Selig praises new supplement law, J.C. Romero awaits apology

Leave a comment

Senators McCain and Dorgan introduced some new legislation today that proposes to more closely regulate the supplement industry in the wake of reports that many products contain designer steroids and other such nasties which aren’t disclosed to the public.  Bud Selig just released a statement on it:

“On behalf of Major League Baseball, I would like to thank Senators
John McCain and Byron Dorgan for their efforts to broaden the Food and
Drug Administration’s regulatory authority over dietary supplements. We
fully support the proposed legislation designed to protect athletes and
consumers from dangerous, mislabeled and tainted over-the-counter
supplements. The continued leadership of Senators McCain and Dorgan has
made an impact on this important issue.”

That’s all good, but if Selig really believed that mislabled and tainted over-the-counter supplements were a problem, why didn’t he buy J.C. Romero’s defense? Romero, you’ll recall, was suspended 50 games for taking something he bought from a GNC store which both he and the MLBPA thought was OK, and contained no evidence that it had bad stuff in it on the label, but turned out to have a banned hormone in it. Baseball didn’t think that got him off the hook and he served his suspension because, according to Major League Baseball, he was “negligent.”

If baseball really thinks guys like Romero were “negligent” then you’d think they’d issue a statement saying that the new law is unnecessary.

UPDATE:  Just had a conversation with someone at Major League Baseball. Their view — which makes a good deal of sense, I’ll admit — is that the drug policy sort of has to take the kind of zero-tolerance approach that was taken in the Romero case, or else enforcement actions are going to be prone to a bunch of “I didn’t know what I was taking” defenses, rendering the policy largely ineffective. Ultimately, the issue is whether a player — despite his intentions — competed in a game with a banned substance in his system. I can see that. Baseball’s drug policy, while having multiple purposes, should probably have “making sure athletes are competing on a level playing field” as its top priority.

But one question I do have is that, if that’s the case, what’s the point of even having an appeals and arbitration process like the one Romero went through in the first place? Why not just a test-positive-no-appeal kind of system? Or at the most an appeals process that only scrutinizes the science of it all, such as whether the test itself was wrongly administered or whether the samples were tainted or what have you?

Dallas Keuchel is unlikely to return before the All-Star break

Getty Images
Leave a comment

Astros’ left-hander Dallas Keuchel might not return to the rotation before the All-Star break, Houston manager A.J. Hinch told reporters prior to Sunday’s game. The club placed their star southpaw on the 10-day disabled list on June 8, retroactive to June 5, after a nerve issue was revealed in his neck.

Keuchel has taken a conservative approach to his recovery over the last several weeks, and while he appears to have made some progress, still has yet to throw off the mound. The injury interrupted the start of an outstanding run with the Astros, during which the 29-year-old lefty furnished a 9-0 record with a 1.67 ERA, 2.1 BB/9 and 8.2 SO/9 through his first 75 2/3 innings of 2017.

According to Hinch, it’s certainly possible that Keuchel could return to the team sometime within the next two weeks, but it’s clear that the team would prefer to play it extra safe with their ace. Even assuming that he feels ready to reclaim his spot on the Astros’ pitching staff, he still needs to complete a few key activities before competing in another game — like throwing off a mound, for example. In the meantime, Lance McCullers Jr. will continue to head Houston’s rotation as they try to build on their 12.5-game lead in the AL West.

 

Hinch’s full comments are below:

The Mets are promoting Tim Tebow to Single-A St. Lucie

Cliff Welch/Icon Sportswire via Getty Images
Leave a comment

Mets GM Sandy Alderson told the media on Sunday that the organization is promoting outfielder Tim Tebow from Single-A Columbia to advanced Single-A St. Lucie, MLB.com’s Anthony DiComo reports.

Tebow, 29, wasn’t hitting particularly well to merit the promotion. Across 241 plate appearances with Columbia, he hit .222/.311/.340 with three home runs and 22 RBI. He had just seven extra-base hits (all doubles) in his most recent 20 games. Alderson, however, defended the decision by citing Tebow’s exit velocity and other metrics.

I think we can all agree that the real reason is that promoting Tebow creates another opportunity for the Mets to sell merchandise with his name on it.

One has to feel for the outfielder Tebow will displace. St. Lucie’s regular outfielders have comparable stats to Tebow’s, so they aren’t exactly being replaced on merit. That outfielder will see less playing time, hurting his future prospects. Adding Tebow to St. Lucie’s roster will push someone off of the roster, which will also harm that player’s future prospects. And, remember, these players don’t make much money to begin with.